Anti-lactoferrin autoantibodies: relation between epitopes and iron-binding domain

Area of Science:

• Immunology
• Autoimmunity
• Rheumatology

Background:

• Anti-neutrophil cytoplasm antibodies (ANCA) are associated with systemic necrotizing microscopic vasculitis.
• Lactoferrin (LF) is an antigen rarely recognized by ANCA, with anti-LF autoantibodies found in various autoimmune conditions.
• The clinical heterogeneity in autoimmune diseases may relate to differing epitope recognition profiles of autoantibodies.

Purpose of the Study:

• To analyze the epitopes recognized by human anti-LF antibodies.
• To investigate whether anti-LF autoantibodies modulate LF's iron-binding activity.
• To determine the clinical and pathophysiological relevance of anti-LF autoreactivity.

Main Methods:

• Monoclonal antibodies were raised against LF and used in competition studies with human sera.
• Epitope mapping was performed to identify distinct binding sites on LF.
• Iron-binding assays using 59Fe were conducted to assess the effect of antibodies on LF's iron chelation capacity.

Main Results:

• Four distinct epitopes on LF were identified, but only one human serum showed epitope-specific binding inhibition.
• Anti-LF autoreactivity was found to be polyclonal, not restricted to a single immunodominant epitope.
• Neither human anti-LF sera nor mouse monoclonal antibodies affected LF's iron binding; only rabbit polyclonal anti-LF antibodies inhibited iron binding.

Conclusions:

• Lactoferrin is a rare antigen specificity for ANCA.
• Anti-LF autoantibodies do not appear to modulate LF's iron-binding activity.
• The clinical and pathophysiological relevance of anti-LF autoreactivity remains uncertain.